Octapharma has received approval from the US Food and Drug Administration (FDA) for a new 2-gram (g) formulation of Fibryga ...

Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...

UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland. The ...

LONDON--(BUSINESS WIRE)--Global procurement intelligence advisory firm, SpendEdge, has announced the release of their ‘Pharmaceutical Formulation Equipment Procurement Research Report.’ The insights ...

OTTAWA, ON / ACCESSWIRE / June 3, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) and Altus Formulation Inc. ("Altus") today announced the launch of TALLC Corporation ...

This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions ...

LONDON--(BUSINESS WIRE)--The Pharmaceutical Formulation Equipment market will register an incremental spend of about USD 7.35 billion, growing at a CAGR of 8.42% during the five-year forecast period.

Greenville, NC, October 09, 2010 --(PR.com)-- Joseph E. "Joe" Cobb Jr., senior formulations scientist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional TM ...

(RTTNews) - Biohaven Pharmaceutical Holding Company Ltd. (BHVN) announced the FDA has authorized the initiation of clinical trials for oral zavegepant. Biohaven Pharma said it has achieved first in ...

Aurobindo Pharma’s wholly owned subsidiary Auro Pharma acquires Khandelwal Laboratories’ non-oncology prescription ...

Pharma Formulations 2020 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about formulations and drug delivery and its advances ...